AzTrials
AzTrials

Osteo Arthritis of the KneeNCT07397806

Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis

A study testing Lex Dexterity Trainer and Wobble Board in people with Osteo Arthritis of the Knee, run by Steadman Philippon Research Institute at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Rationale: Roughly 14 million adults aged 60 or older (10% male/13% female) in the United States experience symptoms of knee osteoarthritis (OA). Knee OA pain progressively impacts aging, reducing mobility and increasing morbidity. Read more about this study

Who is it for?
Ages 40 to 85 years
Conditions the study is for
Osteo Arthritis of the Knee
What is being tested?
Lex Dexterity Trainer and Wobble Board
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteUnited States
Study dates
11 Sep 2025to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 40 to 85 years
  • Ambulatory in home and community settings
  • History of knee osteoarthritis in one or both knees (Kellgren-Lawrence grade II-IV)
  • Baseline pain of 3-10 points on the target (i.e., more-affected) knee and a pain differential of at least -2 points on the contralateral knee as exhibited by the worst pain score for the previous week (on the 11-point Numeric Rating Scale, NRS/Visual Analog Scale VAS).
  • Capacity to personally give informed consent (consent via a legally authorized representative will not be accepted) and who are willing to comply with all study-related procedures and assessments

Who cannot join

  • Previous or Planned Knee Surgeries, Procedures, and/or Treatments:
  • Planned surgery on either the contralateral or target knee at any time during the Study period, including pre-and post-training assessments.
  • Within 6 months of signing informed consent has received diagnostic arthroscopy of the target knee or arthroscopic surgery (including microfracture and meniscectomy) on the target knee;
  • Within 12 weeks of signing informed consent has received intra-articular treatment of the target knee with steroids or hyaluronic acid derivatives;
  • Planned intra-articular treatment of the target knee with steroids or hyaluronic acid derivatives on either the contralateral or target knee at any time during the Study period including pre-and post-training assessments.
  • History of previous total or partial arthroplasty in the target knee. Partial or total arthroplasty in the contralateral knee is acceptable as long as the surgery was performed at least 6 months prior to enrollment and the operative knee is asymptomatic
Show all 13Show fewer
  • Current and/or Previous Medical Conditions, Surgeries, and/or Procedures:
  • Within 2 years of signing informed consent, history of active blood disorders (i.e., DVTs, chronic blood clotting, hemophilia, leukemia, myeloma, etc.); or active malignancy of any type or history of a malignancy (with the exception of subjects with a history of treated basal or squamous cell carcinoma).
  • Current diagnosis of fibromyalgia based on American College of Rheumatology (ACR) criteria.
  • Any active known or suspected systemic autoimmune disease (except for vitiligo, residual auto-immune hypothyroidism requiring hormone replacement only, psoriasis not requiring systemic treatment for two years, conditions not expected to recur in the absence of an external trigger) or any history of systemic inflammatory arthritis such as psoriatic, rheumatoid, ankylosing spondylitis or reactive arthritis.
  • Current or prior history of other joint diseases including but not limited to joint dysplasia, crystal-induced arthropathy (such as gout, or calcium pyrophosphate deposition disease evidenced by clinical and/or radiographic means), aseptic osteonecrosis, acromegaly, Paget's disease, Ehlers-Danlos Syndrome, Gaucher's disease, Stickler syndrome, joint infection, hemochromatosis, or neuropathic arthropathy of any cause.
  • Any medical condition, including findings in laboratory or medical history or in the baseline assessments, that (in the opinion of the Principal Investigator or his designee) constitutes a risk or contraindication for participation in the Study or that could interfere with the Study conduct, endpoint evaluation or prevent the subject from fully participating in all aspects of the Study.
  • Within 8 weeks of signing informed consent, has used opioid analgesics and is not willing to discontinue these medications through the duration of the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sara Robinson, MS contact

970-401-8717

srobinson@sprivail.org

Scott Tashman, PhD contact

970-238-8094

stashman@sprivail.org

United States1 site, 1 recruiting
  • Steadman Philippon Research Institute

    Vail, Colorado, 81657

    Sara Robinson, MS, 970-401-8717, srobinson@sprivail.org

    Scott Tashman, PhD, 970-238-8094, tashman@me.com

    Recruiting

Other trials in United States

About this study

Rationale:

Roughly 14 million adults aged 60 or older (10% male/13% female) in the United States experience symptoms of knee osteoarthritis (OA). Knee OA pain progressively impacts aging, reducing mobility and increasing morbidity. Nonsurgical self-management of knee OA includes exercise to promote proper knee mechanics, non-steroidal anti-inflammatory drugs (NSAIDs), cortisone injections, and weight loss to reduce pain and retain function. As OA has no cure, self-management progresses to ~1 million joint replacements per year. Critically, home-based devices are lacking for specifically training the low-level proprioceptive and neuromuscular circuitry for proper knee mechanics in a safe, focused, mechanistic way. Such devices would supplement exercises for strength, mobility, and whole-body loading and movement.

Read more

Initially considered a wear-and-tear condition, knee OA is now understood as a complex disease involving inflammatory responses to mechanical loading and neuromuscular feedback loops among pain, joint damage, and dynamic loading. Home-based exercises remain a primary nonpharmacological and nonsurgical approach to managing chronic pain in OA that fundamentally disrupts proprioception and neuromuscular control of the joint, which accelerates articular degeneration.

Neuromuscular Dynamics, LLC has developed a simple, safe, quick, and effective Leg Dexterity System that is portable, wireless, and coupled to HIPAA-compliant cloud analytics. A seated participant uses their foot to compress a platform atop a slender spring, which becomes unstable as it begins to buckle at low forces. The participant must then control their leg dexterity (i.e., via short-latency sensorimotor circuits) to stabilize the unstable dynamic foot-ground interactions. A tablet computer connected to the device provides feedback during use and uploads the participant's activity data to the server for analysis and reporting, accessible to users and clinicians.

The investigators have successfully tested Leg Dexterity in control participants in multiple publications. The Leg Dexterity test is safe and poses minimal risk as the forces needed to do it are very low, does not involve full weight- bearing maneuvers, and is performed while seated without the risk of falling.

Study:

The investigators will conduct a randomized home-based clinical trial in knee OA to demonstrate the efficacy of leg dexterity training to reduce pain and improve function compared to currently prescribed dynamic exercise on a wobble board (a commonly used approach for improving proprioception and balance). Successful completion of this study will justify the adoption of the Leg Dexterity System as an effective at-home supplement to any nonsurgical management of knee OA.

The investigators propose a longitudinal double-blind dose-matched trial comparing 8 weeks of leg dexterity training (Treatment using a slender, unstable spring system that engages short-latency sensorimotor control, 42 participants) vs. at-home wobble board exercises (Control, 42 participants) at the Steadman Philippon Research Institute.

Read the detailed description

The investigators will conduct a randomized home-based clinical trial in knee OA to demonstrate the efficacy of leg dexterity training to reduce pain and improve function compared to currently prescribed dynamic exercise on a wobble board (a commonly used approach for improving proprioception and balance). Successful completion of this study will justify the adoption of the Leg Dexterity System as an effective at-home supplement to any nonsurgical management of knee OA.

The investigators propose a longitudinal double-blind dose-matched trial comparing 8 weeks of leg dexterity training (Treatment using a slender, unstable spring system that engages short-latency sensorimotor control, 42 participants) vs. at-home wobble board exercises (Control, 42 participants) at the Steadman Philippon Research Institute.

Primary Hypothesis: Neuromuscular control: Compared to the Control group, the Treatment group will report greater reduction in knee pain and demonstrate improved function in the more-affected leg. The primary outcomes measures will include The Western Ontario and McMaster Universities Arthritis Index (WOMAC) Pain subscale and the Single Limb Stance Test (SLS).

Secondary Hypothesis: Whole-body function: Compared to the Control group, greater OA-related whole-body functional improvements will be found in the Treatment group. Secondary outcome measures include the WOMAC stiffness and physical function subscales; International Knee Documentation Committee (IKDC) Subjective Knee score, Timed-up-and-go test (TUG); 6 min walk test (6MW); 40-meter walk (40mW) Test; and lower-extremity Gait analysis.

The Leg Dexterity System:

To use the Leg Dexterity system, seated individuals are instructed to use a single leg to slowly compress the spring with the platform with the goal to make the force feedback line as high as possible (i.e., maximize vertical compression force) throughout each ~10 second trial without letting the foot slip on the platform (see Figure). The spring begins to show instabilities at low forces. Participants are informed that it is ok for the spring to bend and oscillate (i.e., due to the instability inherent in task). Despite the motion, the goal is to maintain the highest possible force level without the spring buckling (which occurs when the force exceeds 15% of body weight). Because the spring becomes increasingly instable even at these low forces, the maximal sustained compression quantifies their maximal neuromuscular control abilities.

The Wobble Board:

Commercial wobble boards (Core-Tex Reactive Trainer, Core-Tex Fitness, Inc. shown at right). are an intervention used at home and the clinic to improve leg and body dynamic control. As shown, the wobble board is equipped with safety bars to protect against falls and poses minimal risk for older adults and adults with knee OA. To use the wobble board with eyes open, participants will stand on the center of the board and perform 5 repetitions each of: (i) forward/backward and (ii) side-to-side board tilts, and 30 seconds of (iv) single-leg stance on each leg. This wobbleboard protocol is a safe and effective intervention in knee OA[67,68], and participants are encouraged to minimize the use of the handle bars within their comfort level to maximize and improve leg and body dynamic control.

Participant Assignment:

After informed consent, study participants will undergo a baseline assessment and be randomized to receive either the Leg Dexterity device or the wobbleboard. They will then take their assigned device home, with instructions to perform the exercises they were trained on 3 times per week for 8 weeks and maintain a log of their activities. After 8 weeks, they will return to the Steadman Philippon Research Institute for a repeat assessment and to return the equipment.

Establish the clinical feasibility, utility and efficacy of using a home-based Leg Dexterity training program to reduce pain and improve function for individuals with osteoarthritis.

There is a single endpoint at 8 weeks after initiation of training.

  • 82 patient participants with knee osteoarthritis, targeting equal numbers of male and female participants.

This is a Phase II clinical trial, providing an initial assessment of efficacy.

Single-center study conducted at the Steadman Philippon Research Institute in Vail, CO

Participants will be randomized into one of two home treatment regimens, utilizing either the Leg Dexterity system or a commercially available wobbleboard. Training will occur 3 times per week for 8 weeks.

36 months

The initial visit will consist of informed consent, screening, baseline testing and training on the proper use of either the Knee Dexterity system or the wobbleboard. This visit will take approximately 3 hours. Participants will then conduct 8 weeks of home-based training using their assigned device. They will then return for their follow-up visit, during which the assessments performed at baseline will be repeated. This visit will take approximately 90 minutes. The supplied training device will be returned and study participation will be complete. Total study duration for each participant will be approximately 10 weeks.

Being tested
Lex Dexterity Trainer, Wobble Board
Keywords
osteoarthritis, knee, exercise, dexterity
Medical subject headings
Osteoarthritis, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lex Dexterity TrainerDevice

    The Leg Dexterity Trainer is a portable, wireless device. A seated participant uses their foot to compress a platform atop a slender spring, which becomes unstable as it begins to buckle at low forces. The participant must then control their leg dexterity (i.e., via short-latency sensorimotor circuits) to stabilize the unstable dynamic foot-ground interactions.

  • Wobble BoardDevice

    A wobble board is a circular or rectangular board with a rounded base, designed to improve balance, core strength, and coordination by creating an unstable surface that challenges stability.

Study groups in NCT07397806
Study groupRoleWhat they receive
Leg Dexterity TrainingExperimentalFor the Lex Dexterity Training group, participants will be seated at the edge of a standard-height (76 cm) table and instructed to hold on to the edge of the table and support their weight equally through the table and the support leg before placing the foot of the training leg on the device's platform. The training leg will be positioned in a standardized posture (85 - 95° of hip and knee flexion) with the foot on the platform. Participants will press down on the platform ten (10) times, one leg at a time. Subjects will be asked to reach and hold the maximal force they can sustain before the device becomes unstable, thus engaging and training their neuromuscular control of unstable foot-ground interactions. After the initial in-person training session, participants will take the device home, with instructions to complete the training protocol (approximately 10-minute sessions) 3 times per week. The sessions are guided and logged with a tablet-based app.
Receives: Device: Lex Dexterity Trainer
Wobble BoardActive comparatorThe Wobble Board (Control) group will train for 10 minute sessions 3 times per week on a commercially available wobble board, with a safety rail system to provide support and prevent falls. The wobbleboard is a well-known, safe and moderately effective intervention for treating knee OA. This training will consist of 5 repetitions each of: (i) forward/backward and (ii) side-to-side board tilts, and 30 seconds of (iv) single-leg stance on each leg. As previously described, this wobbleboard protocol is a safe and effective intervention in knee OA. As shown, the wobble board is equipped with safety bars to protect against falls. After the initial in-person training session, participants will take the wobble board and safety rails home, with instructions to complete the training protocol (approximately 10-minute sessions) 3 times per week. The sessions are guided and logged with a tablet-based app.
Receives: Device: Wobble Board

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain: Numerical Rating Scale

    Study participants will complete the 11-point Numerical Rating Scale (NRS), which is a simple and frequently used pain assessment tool across both clinical research and clinical practice. The resulting score is a unitless integer ranging from 0 to 10, with 0 being no pain and 10 being the most pain imaginable.

    Measured: Pain will be assessed during the baseline visit and after the 8-week training session.

  2. Pain and Function: WOMAC

    Study participants will complete the Western Ontario McMaster Osteoarthritis Index (WOMAC) pain subscale, which consists of 5 questions about pain experienced during activities like walking, using stairs, and standing. Each item is rated on a 5-point Likert scale from 0 to 4: 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = extreme. Scores from each subsale are summed to produce a unitless pain/function score.

    Measured: Womac will be assessed during the baseline visit and after the 8-week training session.

Secondary outcomes (5)
  1. Single Leg Stance Test: stance time

    During the SLS, participants will be asked to maintain balance on each leg with their arms folded across their chest and eyes closed for at most 30 seconds on both stable (rigid surface) and unstable (e.g., 10 cm thick foam) surfaces on top of two Bertec® force plates with standardized software for SLS (Bertec, Inc., Columbus, OH). Participants will stand on the force plate and lift one foot off the floor (flexing the knee to approximately 60º) at their own pace and balance for up to 30 seconds. Trials will be terminated early upon ground contact with the non-test limb. Participants will complete three repetitions in each condition with each leg (12 total trials, 30 minutes for both legs). The first SLS outcome measure will be stance time.

    Measured: Baseline and after completion of the 8-week training session

  2. Performance-Based Physical Function

    Measures of functional performance will include the 6-minute walk test (6MW), timed-up-and-go test (TUG), and 4-meter walk (4mW) tests. The 6MW test measures the distance walked in 6 minutes to evaluate endurance. The TUG measures the time it takes a patient to rise from an armchair (seat height of 46 cm), walk 3 m, turn, and return to sitting in the same chair without physical assistance. The 4mW will be assessed at the fastest safe speed for each participant and assess the capacity for performance of certain activities (e.g., crossing a street before the light changes). These tests have been established as meaningful outcome measures in older persons with a wide range of conditions and have demonstrated validity and reliability.

    Measured: Baseline and after completion of the 8-week training session

  3. Gait Analysis

    Gait kinematics will be assessed using an 8-camera markerless motion capture system (Dari/Captury) during open-ground, free-speed walking. Three walking trials will be collected, with a minimum of 3 gait cycles per trial. Primary outcomes will be knee flexion angle (min/max/range and side-to-side symmetry) and stride parameters.

    Measured: Baseline and after completion of the 8-week training session

  4. o 12-Item Short Form Health Survey (SF-12)

    The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life.

    Measured: Baseline and after the 8-week training intervention

  5. Single Leg Stance (SLS) test: Center of Mass Displacement

    During the SLS, participants will be asked to maintain balance on each leg with their arms folded across their chest and eyes closed for at most 30 seconds on both stable (rigid surface) and unstable (e.g., 10 cm thick foam) surfaces on top of two Bertec® force plates with standardized software for SLS (Bertec, Inc., Columbus, OH). Participants will stand on the force plate and lift one foot off the floor (flexing the knee to approximately 60º) at their own pace and balance for up to 30 seconds. Trials will be terminated early upon ground contact with the non-test limb. Participants will complete three repetitions in each condition with each leg (12 total trials, 30 minutes for both legs). The second SLS outcome measure will be the mean and maximum displacement of the Center of Pressure (COP) location in mm.

    Measured: Baseline and after completion of the 8-week training session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2026
  2. Study start11 Sep 2025
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
82 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07397806
Sponsor's protocol ID
NMD-OA-2024
Other IDs
R44AG090114
Status last verified
Feb 2026
First submitted
26 Jan 2026
Last updated
9 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Individual participant data that underlie the reported results, after deidentification

Questions about this trial

What is this clinical trial studying?

A study testing Lex Dexterity Trainer and Wobble Board in people with Osteo Arthritis of the Knee, run by Steadman Philippon Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sara Robinson, MS (970-401-8717, srobinson@sprivail.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain: Numerical Rating Scale (time frame: Pain will be assessed during the baseline visit and after the 8-week training session.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in